-
Cost Impact of the Porcine Urinary Bladder Matrix in Patients With Diabetic Foot Ulcer in the United Kingdom
Sep 9, 2025, 16:22 PM -
The Societal Value of Lecanemab for Patients With Early Alzheimer's Disease in Japan
Sep 9, 2025, 16:22 PM -
Respiratory Syncytial Virus (RSV) Knowledge and Perceived RSV Risk Groups Amongst GP/PCPs and Specialists in APAC: A Cross-Sectional Knowledge Attitude and Practices Survey (RESVIKAP)
Sep 9, 2025, 16:22 PM -
Analysis of Pooled Real-World Utilization and Outcomes Data of rVIII-Single Chain Compared With Standard and Extended Half-Life FVIII Products for Prophylaxis of Hemophilia A in France, Germany, and Italy
Sep 9, 2025, 16:22 PM -
The Five-Year Budget Impact of Introducing Semaglutide 2.4 mg for Obesity Management in Saudi Arabia: A Real-World Patient Flow and Complication-Driven Model
Sep 9, 2025, 16:22 PM -
Dealing With Missing Data in Health Economic Studies of Small to Moderate Size: How to Minimize Bias
Sep 9, 2025, 16:22 PM -
Breast Cancer Overall Survival in France
Sep 9, 2025, 16:22 PM -
Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Fixed-Dose Combination Rosuvastatin and Ezetimibe vs. Simvastatin Plus Ezetimibe for the Treatment of Hypercholesterolemia in Patients at High Risk and Very High Risk of Cardiovascular Disease in Algeria
Sep 9, 2025, 16:22 PM -
Comparative Prevalence of Suicidal Ideation and Self-Harm History: Rexulti vs. Other Oral Atypical Antipsychotics
Sep 9, 2025, 16:22 PM -
Impact of CFTR Modulator Initiation on Direct Medical Costs for People With Cystic Fibrosis
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan vs. C5 Inhibitors in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitors in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
The Value of Persistence in Neovascular Age-Related Macular Degeneration
Sep 9, 2025, 16:22 PM -
Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
Modeling Physician Prescribing Decisions Based on Patient Characteristics for Positioning of a Novel Treatment Entering a Well-Established Category
Sep 9, 2025, 16:22 PM -
Market Access AI Readiness: Maximizing Strategic Alignment Through Organizational Insights
Sep 9, 2025, 16:22 PM -
The Association Between COVID-19 Vaccination and the Healthcare Resource Use Related to COVID-19 in Typical Rural Residents in Japan
Sep 9, 2025, 16:22 PM -
Does the Joint Clinical Assessment (JCA) Enable Health Equity Across Europe? A Review of HTA Practices in the EU
Sep 9, 2025, 16:22 PM -
Food and Health Literacy Among University Students: Sociodemographic Insights
Sep 9, 2025, 16:22 PM
